Research

Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | October 16, 2019
Blog Post

Clinical Trial Alert: Momenta Pharmaceuticals Seeks Participants for a Phase 2 Myasthenia Gravis Study

By MDA Staff | October 15, 2019
Blog Post

NS Pharma Submits New Drug Application to FDA for Viltolarsen to Treat DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | October 7, 2019
Blog Post

At a Cedars-Sinai Care Center, Dr. Robert Baloh Looks Under — and Ahead of — the Microscope for CMT and ALS

By Lindsey Baker | October 1, 2019
Blog Post

Five Questions with LGMD Researcher Martin Childers

By Jeanene Swanson | September 30, 2019
Blog Post

MDA Awards Clinical Research Network Grant to CMT Researcher Michael Shy for Inherited Neuropathies Consortium

By Jeanene Swanson | September 27, 2019
MDA logo
Blog Post

In a Letter to the Duchenne Community, Santhera Announces Positive Results of Phase 2 Vamorolone Study, EMA’s Review of Puldysa to Treat Symptoms of DMD

By MDA Staff | September 26, 2019
Blog Post

Clinical Trial Alert: Italfarmaco Seeks Participants for a Phase 3 DMD Study

By MDA Staff | September 25, 2019
Blog Post

Five Questions with Friedreich’s Ataxia Researcher Sanjay Bidichandani

By Jeanene Swanson | September 25, 2019
Blog Post

Researcher with CMT Awarded MDA Funding to Discover Rare Variants for Multiple Neuromuscular Diseases

By Jeanene Swanson | September 23, 2019